M&A Deal Summary |
|
|---|---|
| Date | 2020-08-19 |
| Target | Medlight S.A. |
| Sector | Medical Products |
| Buyer(s) | Rakuten Medical |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2010 |
| Sector | Life Science |
Rakuten Medical is a global biotechnology company developing precision, cell-targeting investigational therapies on its IlluminoxTM platform, which, in preclinical studies have shown to lead to rapid and selective cell killing and tumor necrosis. Illuminox therapies have not yet been approved by any regulatory authority. Rakuten Medical was formed in 2010 and is based in San Diego, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Switzerland M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |